心臟假体设备市场规模、份额和成长分析（按产品类型、材质类型、最终用途和地区划分）－2026-2033年产业预测

全球心臟瓣膜装置市场规模预计在 2024 年达到 74.7 亿美元，从 2025 年的 80.5 亿美元增长到 2033 年的 146.9 亿美元，在预测期（2026-2033 年）内复合年增长率为 7.8%。

全球心臟瓣膜假体市场的主要驱动力是人口老化。随着人口老化，心血管系统发生结构和功能变化，导致主动脉瓣狭窄和心臟衰竭等疾病的风险增加。这种人口结构变化导致退化性心臟疾病的发生率不断上升，需要透过手术或经皮治疗来植入人工瓣膜和心律调节器。因此，由于住院和医疗手术的增加，对先进心臟瓣膜假体的需求激增。此外，技术创新也发挥关键作用，例如微创治疗方法方案、生物相容性材料和3D列印瓣膜等技术的进步提高了安全性、有效性和长期治疗效果。这些进步，加上透过智慧监测解决方案改善的术后护理以及更广泛的治疗选择，确保了市场的持续成长。

推动全球心臟瓣膜器械市场发展的因素

全球心臟病发生率的不断上升是推动全球心臟瓣膜假体市场扩张的关键因素。随着瓣膜性心臟病和冠状动脉疾病等疾病的日益普遍，对心臟瓣膜和血管移植物等人工瓣膜置换解决方案的需求也日益增长。这种需求的激增不仅推动了销售，也促进了行业内的进步和创新，为心臟医疗技术的成长和发展创造了充满活力的环境。因此，应对这些健康挑战的持续努力将继续推动市场向前发展，从而为患者带来更好的治疗选择。

限制全球心臟假体市场的因素

全球心臟假体市场面临着漫长而复杂的监管核准流程带来的巨大挑战。严格的监管要求，以及全面的临床试验和广泛的测试，都可能阻碍新器械的及时上市。这种漫长的核准流程不仅扼杀了创新，也限制了患者获得最新心臟技术的机会。因此，市场遭受的延误阻碍了潜在救命解决方案的推出，最终影响了患者照护和心臟疾病治疗的整体进展。

全球心臟假体市场趋势

全球心臟瓣膜假体市场正日益倾向于微创手术，这反映了患者的偏好和临床实践的关键趋势。经导管心臟瓣膜和导管修復系统等创新器械因其能够缩短恢復时间并降低相关风险（与传统手术方法相比）而备受青睐。切口较小的手术方式不仅提高了患者的舒适度，还改善了整体治疗效果，从而推动了对这些技术的需求。在这些微创解决方案的推动下，随着医疗机构优先考虑效率和患者满意度，市场预计将持续成长。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 监管环境
• 案例研究
• 技术分析

全球心臟假体市场规模（按产品类型和复合年增长率划分）（2026-2033 年）

• 心臟瓣膜
  • 机械心臟瓣膜
  • 生物瓣膜
  • 经导管心臟瓣膜置换术（TAVR）
• 起搏器
  • 植入式心臟节律器
  • 体外心律调节器
• 其他的
  • 心室辅助装置（VAD）
  • 全人工心臟（TAH）

全球心臟假体市场规模（按材料类型和复合年增长率划分）（2026-2033 年）

• 生物基材料
  • 牛
  • 猪组织
• 合成材料
  • 钛
  • 聚氨酯
  • 碳
• 混合材料

全球心臟假体市场规模（按最终用途和复合年增长率划分）（2026-2033 年）

• 医院
• 心臟中心和诊所
• 门诊手术中心
• 其他的

全球心臟假体市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2023-2025年营收年比比较

主要企业简介

• Abbott Laboratories（USA）
• Medtronic plc（Ireland）
• Boston Scientific Corporation（USA）
• Edwards Lifesciences Corporation（USA）
• LivaNova PLC（UK）
• Biotronik（Germany）
• MicroPort Scientific Corporation（China）
• Meril Life Sciences Pvt. Ltd.（India）
• Lepu Medical Technology Co., Ltd.（China）
• CryoLife, Inc.（USA）
• AtriCure, Inc.（USA）
• Braile Biomedica（Brazil）
• Labcor Laboratorios Ltda.（Brazil）
• Lifetech Scientific Corporation（China）
• Shree Pacetronix Ltd.（India）
• TTK Healthcare Ltd.（India）
• Colibri Heart Valve LLC（USA）
• Berlin Heart GmbH（Germany）
• SynCardia Systems LLC（USA）
• Venus Medtech（Hangzhou）Inc.（China）

结论与建议

Global Cardiac Prosthetic Devices Market size was valued at USD 7.47 Billion in 2024 and is poised to grow from USD 8.05 Billion in 2025 to USD 14.69 Billion by 2033, growing at a CAGR of 7.8% during the forecast period (2026-2033).

The global market for cardiac prosthetic devices is primarily driven by the growing elderly population, which experiences structural and functional changes in the cardiovascular system, increasing susceptibility to conditions such as aortic stenosis and heart failure. This demographic shift leads to a heightened incidence of degenerative heart diseases, necessitating surgical or percutaneous interventions involving prosthetic valves or pacemakers. Consequently, there is a surging demand for advanced cardiac prosthetic devices, influenced by rising hospital admissions and medical procedures. Additionally, technological innovations play a crucial role, with developments such as minimally invasive options, biocompatible materials, and 3D-printed valves enhancing safety, effectiveness, and long-term outcomes. These advancements not only improve post-operative care through smart monitoring solutions but also expand treatment options, ensuring sustained market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cardiac Prosthetic Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cardiac Prosthetic Devices Market Segments Analysis

Global Cardiac Prosthetic Devices Market is segmented by Product Type, Material Type, End-Use and region. Based on Product Type, the market is segmented into Heart Valves, Pacemakers and Others. Based on Material Type, the market is segmented into Biological Materials, Synthetic Materials and Hybrid Materials. Based on End-Use, the market is segmented into Hospitals, Cardiac Centers and Clinics, Ambulatory Surgical Centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Cardiac Prosthetic Devices Market

The increasing prevalence of cardiac diseases worldwide serves as a significant catalyst for the expansion of the global cardiac prosthetic devices market. As conditions such as heart valve disease and coronary artery conditions become more common, there is a heightened demand for prosthetic solutions like heart valves and vascular grafts. This surge in need not only drives sales but also encourages advancements and innovation within the industry, creating a dynamic environment for growth and development in cardiac healthcare technologies. Consequently, the ongoing battle against these health challenges continues to propel the market forward, leading to enhanced treatment options for patients.

Restraints in the Global Cardiac Prosthetic Devices Market

The Global Cardiac Prosthetic Devices market faces significant challenges due to lengthy and complex regulatory approval processes. The stringent regulatory requirements, coupled with the need for comprehensive clinical trials and extensive testing, can impede the timely introduction of new devices. This protracted approval timeline not only stifles innovation but also limits patient access to the latest advancements in cardiac technology. As a result, the market may suffer from delays that prevent the adoption of potentially life-saving solutions, ultimately impacting patient care and overall progress in treating cardiac conditions.

Market Trends of the Global Cardiac Prosthetic Devices Market

The global cardiac prosthetic devices market is increasingly gravitating towards advancements in minimally invasive procedures, reflecting a significant trend in patient preference and clinical practice. These innovative devices, such as transcatheter heart valves and catheter-based repair systems, are gaining traction due to their ability to promote quicker recovery times and lower associated risks compared to traditional surgical approaches. The shift towards smaller incisions not only enhances patient comfort but also improves overall outcomes, driving demand for these technologies. As healthcare providers prioritize efficiency and patient satisfaction, the market is expected to see continued growth fueled by these minimally invasive solutions.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technological Analysis

Global Cardiac Prosthetic Devices Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Heart Valves
  • Mechanical Heart Valves
  • Tissue Heart Valves
  • Transcatheter Heart Valves (TAVR)
• Pacemakers
  • Implantable Pacemakers
  • External Pacemakers
• Others
  • Ventricular Assist Devices (VADs)
  • Total Artificial Hearts (TAH)

Global Cardiac Prosthetic Devices Market Size by Material Type & CAGR (2026-2033)

• Market Overview
• Biological Materials
  • Bovine Pericardium
  • Porcine Tissue
• Synthetic Materials
  • Titanium
  • Polyurethane
  • Carbon
• Hybrid Materials

Global Cardiac Prosthetic Devices Market Size by End-Use & CAGR (2026-2033)

• Market Overview
• Hospitals
• Cardiac Centers and Clinics
• Ambulatory Surgical Centers
• Others

Global Cardiac Prosthetic Devices Market Size & CAGR (2026-2033)

• North America (Product Type, Material Type, End-Use)
  • US
  • Canada
• Europe (Product Type, Material Type, End-Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Material Type, End-Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Material Type, End-Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Material Type, End-Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Edwards Lifesciences Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LivaNova PLC (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotronik (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroPort Scientific Corporation (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meril Life Sciences Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lepu Medical Technology Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CryoLife, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AtriCure, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Braile Biomedica (Brazil)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Labcor Laboratorios Ltda. (Brazil)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lifetech Scientific Corporation (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shree Pacetronix Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TTK Healthcare Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Colibri Heart Valve LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Berlin Heart GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SynCardia Systems LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Venus Medtech (Hangzhou) Inc. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations